Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: HPB (Oxford). 2020 Sep 17;23(4):551–559. doi: 10.1016/j.hpb.2020.08.013

Table 4.

Multivariable Analysis for Patients with Grade B/C PHLF

Grade B/C PHLF
n (%)
Adjusted Odds Ratio
(95% CI)
P value
Age, mean (SD)* 65.0 (10.5) 1.19 (0.99 - 1.42) 0.069
Sex
 Male 65 (1.9) 1.00 (REF) -
 Female 35 (1.0) 0.93 (0.59 - 1.46) 0.739
ASA Class
 I/II 10 (0.5) 1.00 (REF) -
 III/IV/V 90 (1.8) 1.99 (0.98 - 4.05) 0.057
Ascites 6 (12.5) 4.63 (1.56 - 13.78) 0.006
Bleeding disorder 14 (5.6) 2.62 (1.09 - 6.32) 0.032
Elevated SGOT > 40 50 (4.1) 2.51 (1.72 - 3.64) < 0.001
Surgical Pathology
 Benign 6 (0.3) 1.00 (REF) -
 Primary Hepatobiliary 70 (3.2) 4.03 (2.12 - 7.64) < 0.001
 Secondary/Unknown 24 (0.8) 1.79 (0.94 - 3.40) 0.074
Operative Time (hours), mean (SD)** 259.1 (130.8) 1.16 (1.06 - 1.27) 0.002
Surgical Approach
 Minimally Invasive 12 (0.6) 1.00 (REF) -
 Open/Other 88 (1.8) 2.42 (1.44 - 4.06) < 0.001
Liver Texture
 Normal/Not documented 47 (0.9) 1.00 (REF) -
 Cirrhotic/Congested/Fatty/Fibrotic 53 (3.1) 2.18 (1.40 - 3.39) < 0.001
Pringle Maneuver 29 (2.3) 1.35 (0.75 - 2.41) 0.315
Surgical Drain 56 (2.0) 1.21 (0.78 - 1.88) 0.401
*

OR reported for each additional 10 years

**

OR reported for each additional hour

Abbreviations: PHLF, post-hepatectomy liver failure; SD, standard deviation; ASA, American Society of Anesthesiologists Classification; SGOT, aspartate transaminase; MIS, minimally invasive surgery